ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
|
phenotype |
|
Finding
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Alveolitis, Fibrosing
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
91
|
4
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Weight Gain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
124
|
12
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Heroin Smoking
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Venous Engorgement
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Heroin Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
100
|
110
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Arthritis, Adjuvant-Induced
|
disease |
Musculoskeletal Diseases
|
Experimental Model of Disease
|
43
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Regional enteritis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
46
|
15
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
heroin abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
22
|
6
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hyperlipoproteinemias
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
49
|
7
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Diabetic Cardiomyopathies
|
disease |
Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
220
|
1
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |
Brain Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
114
|
11
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hyperthyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
279
|
27
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
growth hormone treatment
|
disease |
|
Disease or Syndrome
|
20
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
atrial fibrillation new onset
|
disease |
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
82
|
4
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Headache Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
genetic hypertension
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
34
|
2
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Microalbuminuric diabetic nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
< 0.001 |
1 |
|
2004 |
2004 |